KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Dividends Paid - Common (2009 - 2012)

Novartis Ag recorded quarterly Dividends Paid - Common of -$3.0 in Q2 2012, up 81.25% quarter-over-quarter from -$16.0 in Q2 2011, and up 81.25% year-over-year from -$1.66 in Q3 2011.

Novartis Ag's Dividends Paid - Common history runs 4 years deep, the most recent figure standing at -$3.0 for Q2 2012.

  • In Q2 2012, Dividends Paid - Common rose 81.25% year-over-year to -$3.0; the TTM figure through Jun 2012 stood at -$4505.0 (changed 0.16% YoY), while the FY2025 annual figure was $7.8 billion, up 2.54% from the prior year.
  • Dividends Paid - Common came in at -$3.0 for Q2 2012 at Novartis Ag, up from -$16.0 in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of -$3.0 in Q2 2012 to a low of -$4468.0 in Q1 2010.
  • A 4-year average of -$1409.3 and a median of -$17.0 in 2010 frame the typical range for Dividends Paid - Common.
  • Across the five-year window, Dividends Paid - Common plunged 80.0% in 2010 and surged 81.25% in 2012, its largest moves.
  • Novartis Ag's Dividends Paid - Common stood at -$10.0 in 2009, then slumped by 80.0% to -$18.0 in 2010, then increased by 11.11% to -$16.0 in 2011, then soared by 81.25% to -$3.0 in 2012.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered -$3.0, -$16.0, and -$18.0 for Q2 2012, Q2 2011, and Q2 2010 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 1.55 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 3.13 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 3.09 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 2.11 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1.04 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2.45 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.28 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2012 -3.00
Jun 30, 2012 -3.00
Jun 30, 2011 -16.00
Jun 30, 2011 -16.00
Jun 30, 2010 -18.00
Jun 30, 2010 -18.00
Mar 31, 2010 -4,468.00
Mar 31, 2010 -4,468.00
Jun 30, 2009 -10.00
Jun 30, 2009 -10.00
Mar 31, 2009 -3,941.00
Mar 31, 2009 -3,941.00